Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 2529 entries
View as:

Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00239902 Org: User:
Start: 05/31/02 End: - Due: -

A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01106508 Org: User:
Start: 10/31/10 End: 06/30/15 Due: 06/30/16

Phase I/Ib Trial of LSZ102 Single Agent or LSZ102 + LEE011 or LSZ102 + BYL719 in ER+ Breast Cancers

Phase: N/A Priority: Normal
NCT ID: NCT02734615 Org: User:
Start: 06/14/16 End: 09/13/21 Due: 09/13/22

Cyclosporine A C-2h Monitoring Versus Tacrolimus C-0h Monitoring in de Novo Liver Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00149994 Org: User:
Start: 12/31/02 End: 12/31/07 Due: 12/31/08

A 12 -Month, Open-label, Multi-center Study to Explore the Health Outcomes of FTY720

Phase: N/A Priority: Normal
NCT ID: NCT01578330 Org: User:
Start: 10/31/12 End: 04/30/15 Due: 04/30/16

Study of Muscle Effects of BYM338 in Mechanically Ventilated Patients

Phase: N/A Priority: Normal
NCT ID: NCT01868685 Org: User:
Start: 04/30/14 End: 01/31/15 Due: 01/31/16

MAP to Provide Access to Nilotinib, for Patients With HES

Phase: N/A Priority: Normal
NCT ID: NCT04498871 Org: User:
Start: - End: - Due: -

A Safety and Efficacy Study of LGH447 in Patients With Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)

Phase: N/A Priority: Normal
NCT ID: NCT02078609 Org: User:
Start: 03/20/14 End: 04/18/19 Due: 04/18/20

Long Term Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01237873 Org: User:
Start: 01/31/11 End: 02/29/12 Due: 02/28/13

Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma

Phase: N/A Priority: Normal
NCT ID: NCT03226392 Org: User:
Start: 10/31/17 End: 08/01/19 Due: 08/01/20

Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction

Phase: N/A Priority: Normal
NCT ID: NCT02884206 Org: User:
Start: 11/23/16 End: 05/16/22 Due: 05/16/23

Efficacy, Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail

Phase: N/A Priority: Normal
NCT ID: NCT00443898 Org: User:
Start: 12/31/06 End: - Due: -

Lapatinib +Capecitabine Treatment for Advanced Metastatic Breast Cancer in Women From China

Phase: N/A Priority: Normal
NCT ID: NCT00508274 Org: User:
Start: 07/18/07 End: 07/01/20 Due: 07/01/21

Study to Assess the Pharmacokinetics of Pelacarsen (TQJ230) in Participants With Mild Hepatic Impairment Compared to Matched Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05026996 Org: User:
Start: 11/23/21 End: 10/19/22 Due: 10/19/23

Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00375752 Org: User:
Start: 06/01/06 End: 12/16/10 Due: 12/16/11

A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia.

Phase: N/A Priority: Normal
NCT ID: NCT02034006 Org: User:
Start: 06/10/14 End: 07/15/16 Due: 07/15/17

Vildagliptin Glycemic Profiles Assessment Using a Continuous Glucose Monitoring Device.

Phase: N/A Priority: Normal
NCT ID: NCT01262586 Org: User:
Start: 11/30/10 End: 03/31/11 Due: 03/31/12

This Was a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS).

Phase: N/A Priority: Normal
NCT ID: NCT03713619 Org: User:
Start: 01/31/19 End: 07/26/22 Due: 07/26/23

NVA237 BID Versus Placebo Twelve-week Efficacy Study

Phase: N/A Priority: Normal
NCT ID: NCT01715298 Org: User:
Start: 11/30/12 End: 12/31/13 Due: 12/31/14

An Indian Multi-centric Phase IV Study to Assess the Safety of Crizanlizumab in Sickle Cell Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT04662931 Org: User:
Start: 07/14/21 End: 02/14/24 Due: 02/14/25

A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study

Phase: N/A Priority: Normal
NCT ID: NCT06531499 Org: User:
Start: 11/11/24 End: 02/09/28 Due: 02/09/29

Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

Phase: N/A Priority: Normal
NCT ID: NCT05935215 Org: User:
Start: 02/28/24 End: 07/19/29 Due: 07/19/30

Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Lupus Nephritis.

Phase: N/A Priority: Normal
NCT ID: NCT03610516 Org: User:
Start: 09/12/18 End: 06/29/23 Due: 06/29/24

Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis.

Phase: N/A Priority: Normal
NCT ID: NCT04065841 Org: User:
Start: 12/30/19 End: 10/27/22 Due: 10/27/23

Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01596647 Org: User:
Start: 05/31/12 End: 07/31/14 Due: 07/31/15